01448nam 2200397Ia 450 991069897700332120090618152714.0(CKB)5470000002398103(OCoLC)402662444(EXLCZ)99547000000239810320090618d2005 ua 0enguran|||||||||txtrdacontentcrdamediacrrdacarrierGuidance for industry[electronic resource] E14 clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugsRockville, MD :U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research :Center for Biologics Evaluation and Research,[2005]16 pages digital, PDF fileTitle from PDF title page (viewed on June 18, 2009)."ICH"."October 2005".Guidance for industry DrugsTestingPalpitationDrugsTesting.Palpitation.Center for Drug Evaluation and Research (U.S.)Center for Biologics Evaluation and Research (U.S.)International Conference on Harmonisation.GPOGPOBOOK9910698977003321Guidance for industry3434577UNINA